Literature DB >> 30207577

Association of Anti-Ro/Sjögren's syndrome type A Antibodies and Complete Atrioventricular Block in an Adult With Sjögren's Syndrome.

Weng Kin Tam1, Hui Ching Hsu2,3, Ming Hsiung Hsieh4,3, Jong Shiuan Yeh4,3, Weng Chio Tam4,3.   

Abstract

A 57-year-old female patient with underlying hypertension, dyslipidemia, membranous glomerulonephritis, and Sjögren's syndrome presented to our clinic with near-syncope and dizziness symptoms. We detected non-conducted sinus beat in 12-lead electrocardiography. An echocardiography showed that the left ventricular systolic function was preserved without a regional wall abnormality. The patient did not have symptoms of congestive heart failure or recent myocardial infarction. We observed complete atrioventricular block with longest pause of 6.2 seconds in a 24-hour Holter electrocardiography, and subsequently implanted a permanent pacemaker. Anti-Ro/Sjögren's syndrome type A antibodies are commonly seen in Sjögren's syndrome and associated with a neonatal complete heart block. The pathogenesis of anti-Ro/Sjögren's syndrome type A antibodies in the conduction system of an adult heart is still uncertain. In this article, we report Sjögren's syndrome in an adult patient with complete atrioventricular block and membranous glomerulonephritis, which may be associated with a positive titer of anti-Ro/Sjögren's syndrome type A antibodies.

Entities:  

Keywords:  Anti-Ro/Sjögren’s syndrome type A antibodies; Sjögren’s syndrome; complete atrioventricular block

Year:  2017        PMID: 30207577      PMCID: PMC6117129          DOI: 10.5606/ArchRheumatol.2018.6492

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN: 2148-5046            Impact factor:   1.472


  19 in total

Review 1.  Resolution of complete heart block after prednisolone in a patient with systemic lupus erythematosus.

Authors:  L-T Lim; F Joshua
Journal:  Lupus       Date:  2005       Impact factor: 2.911

Review 2.  Complete atrioventricular block in adult Sjögren's syndrome with anti-Ro autoantibody.

Authors:  Myung Jun Sung; Sung-Hoon Park; Seong-Kyu Kim; Young-Soo Lee; Chul-Yeon Park; Jung-Yoon Choe
Journal:  Korean J Intern Med       Date:  2011-06-01       Impact factor: 2.884

Review 3.  Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: clinical evidence, putative mechanisms, and therapeutic implications.

Authors:  Pietro Enea Lazzerini; Pier Leopoldo Capecchi; Franco Laghi-Pasini
Journal:  Heart Rhythm       Date:  2014-10-29       Impact factor: 6.343

Review 4.  Chloroquine cardiomyopathy - a review of the literature.

Authors:  Ernst Tönnesmann; Reinhard Kandolf; Thorsten Lewalter
Journal:  Immunopharmacol Immunotoxicol       Date:  2013-05-01       Impact factor: 2.730

5.  Complete heart block as the initial manifestation of systemic lupus erythematosus.

Authors:  W P Maier; H E Ramirez; S B Miller
Journal:  Arch Intern Med       Date:  1987-01

6.  [Three patients with nephrotic syndrome due to membranous nephropathy complicated by Sjögren's syndrome].

Authors:  Akiko Baba; Seiichiro Hara; Yuji Sato; Kazuhiro Yamada; Shouichi Fujimoto; Tanenao Eto
Journal:  Nihon Jinzo Gakkai Shi       Date:  2005

7.  Differences in transient outward current properties between neonatal and adult human atrial myocytes.

Authors:  Yanggan Wang; Huaying Xu; Rajiv Kumar; Srinivas M Tipparaju; Mary B Wagner; Ronald W Joyner
Journal:  J Mol Cell Cardiol       Date:  2003-09       Impact factor: 5.000

8.  Complete atrioventricular block as initial manifestation of systemic lupus erythematosus.

Authors:  C A Arce-Salinas; M A Carmona-Escamilla; F Rodríguez-García
Journal:  Clin Exp Rheumatol       Date:  2009 Mar-Apr       Impact factor: 4.473

9.  Cardiac damage in polymyositis associated with antibodies to tissue ribonucleoproteins.

Authors:  W M Behan; P O Behan; J Gairns
Journal:  Br Heart J       Date:  1987-02

Review 10.  Renal involvement in autoimmune connective tissue diseases.

Authors:  Andreas Kronbichler; Gert Mayer
Journal:  BMC Med       Date:  2013-04-04       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.